Ionizing radiation and leukemia mortality among Japanese atomic bomb survivors, 19502000

Radiation Research

Volumn 172, Issue 3, 2009, Pages 368-382

  Richardson, David ^a   Sugiyama, Hiromi ^b   Nishi, Nobuo ^b   Sakata, Ritsu ^b   Shimizu, Yukiko ^b   Grant, Eric J ^b   Soda, Midori ^b   Hsu, Wan Ling ^c   Suyama, Akihiko ^b   Kodama, Kazunori ^c   Kasagi, Fumiyoshi ^b  

^a IL   (United States)

^b RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^c Radiation Effects Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; ATOMIC BOMB SURVIVOR; BONE MARROW; CANCER MORTALITY; CHILD; CHRONIC MYELOID LEUKEMIA; DOSE RESPONSE; FEMALE; HUMAN; IONIZING RADIATION; JAPANESE; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; SCHOOL CHILD; T CELL LEUKEMIA; AGE DISTRIBUTION; ATOMIC WARFARE; ENVIRONMENTAL EXPOSURE; JAPAN; MIDDLE AGED; MORTALITY; SEX RATIO; STATISTICS; SURVIVAL; SURVIVAL RATE; SURVIVOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; JAPAN; LEUKEMIA, RADIATION-INDUCED; MALE; MIDDLE AGED; NUCLEAR WARFARE; SEX DISTRIBUTION; SURVIVAL ANALYSIS; SURVIVAL RATE; SURVIVORS; YOUNG ADULT;

EID: 70349931476     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1801.1     Document Type: Article

References (27)

1. Committee for the Compilation of Materials on Damage Caused by the Atomic Bombs in Hiroshima and Nagasaki, Hiroshima and Nagasaki: The Physical, Medical, and Social Effects of the Atomic Bombings. Basic Books, New York, 1981.
2. A. A. Liebow, S. Warren and E. DeCoursey, Pathology of atomic bomb casualties. Am. J. Pathol. 25, 853-1027 (1949).
3. J. H. Folley, W. Borges and T. Yamawaki, Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan. Am. J. Med. 13, 311-321 (1952).
4. T. Francis, S. Jablon and F. E. Moore, Report of the ad hoc Committee for Appraisal of ABCC Programs. Memorandum dated 6 November 1955, addressed to Dr. R. Keith Cannan, Chairman, Division of Medical Sciences, NAS-NRC. Atomic Bomb Casualty Commission, Hiroshima, 1955.
5. M. Ishida and G. W. Beebe, Joint JNIH-ABCC Study of Life-Span in Atomic Bomb Survivors; Research Plan. TR-33-59, Atomic Bomb Casualty Commission, Hiroshima, 1959.
6. D. L. Preston, S. Kusumi, M. Tomonaga, S. Izumi, E. Ron, A. Kuramoto, N. Kamada, H. Dohy, T. Matsui and K. Mabuchi, Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat. Res. 137 (Suppl.), S68-S97 (1994);
7. Erratum, Radiat. Res. 139, 129 (1994).
8. Y. Shimizu, W. J. Schull and H. Kato, Cancer risk among atomic bomb survivors. The RERF Life Span Study. Radiation Effects Research Foundation. J. Am. Med. Assoc. 264, 601-604 (1990).
9. National Research Council, Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. National Academies Press, Washington, DC, 2006.
10. D. L. Preston, D. A. Pierce, Y. Shimizu, H. M. Cullings, S. Fujita, S. Funamoto and K. Kodama, Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat. Res. 162, 377-389 (2004).
11. D. L. Preston, H. Kato, K. J. Kopecky and S. Fujita, Studies of the mortality of A-bomb survivors, report 8. Cancer mortality, 1950-1982. Radiat. Res. 111, 151-178 (1987).
12. M. Tomonaga, T. Matsuo, R. L. Carter, J. M. Bennett, K. Kuriyama, F. Imanaka, S. Kusumi, K. Mabuchi, A. Kuramoto and S. C. Finch, Differential Effects of Atomic Bomb Irradiation in Inducing Major Leukemia Types: Analyses of Open-City Cases Including the Life Span Study Cohort Based upon Updated Diagnostic Systems and the Dosimetry System 1986 (DS86). pp. 1-26TR 9-91, RERF, Hiroshima, 1991.
13. A. B. Brill and R. M. Heyssel, Leukemia in Humans Following Exposure to Ionizing Radiation. ABCC, Hiroshima, 1959.
14. K. Mabuchi, M. Soda, E. Ron, M. Tokunaga, S. Ochikubo, S. Sugimoto, T. Ikeda, M. Terasaki, D. L. Preston and D. E. Thompson, Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat. Res. 137 (Suppl.), S1-S16 (1994).
15. R. W. Young and G. D. Kerr, Reassessment of the Atomic-Bomb Radiation Dosimetry for Hiroshima and Nagasaki - DS02. RERF, Hiroshima, 2005.
16. D. A. Pierce, D. O. Stram and M. Vaeth, Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat. Res. 123, 275-284 (1990).
17. F. E. Harrell, Jr., K. L. Lee and B. G. Pollock, Regression models in clinical studies: determining relationships between predictors and response. J. Natl. Cancer Inst. 80, 1198-1202 (1988).
18. C. de Boor, A Practical Guide to Splines. Springer-Verlag, New York, 1978.
19. D. L. Preston, J. H. Lubin, D. A. Pierce and M. E. McConney, Epicure: User's Guide. Hirosoft International Corporation, Seattle, WA, 1993.
20. United Nations Scientific Committee on the Effects of Atomic Radiation, Sources and Effects of Ionizing Radiation. United Nations, New York, 2000.
21. S. Greenland, Relation of probability of causation to relative risk and doubling dose: a methodologic error that has become a social problem. Am. J. Public Health 89, 1166-1169 (1999).
22. K. Arisawa, M. Soda, M. Akahoshi, S. Fujiwara, H. Uemura, M. Hiyoshi, H. Takeda, W. Kashino and A. Suyama, Human T-cell lymphotropic virus type-1 infection and risk of cancer: 15.4 year longitudinal study among atomic bomb survivors in Nagasaki, Japan. Cancer Sci. 97, 535-539 (2006).
23. G. W. Beebe, M. Ishida and S. Jablon, Life Span Study Report Number 1: Description of Study. Mortality in the Medical Subsample, October 1950-June 1958. ABCC, Hiroshima, 1961.
24. N. Nishi, H. Sugiyama, W. L. Hsu, M. Soda, F. Kasagi, K. Mabuchi and K. Kodama, Differences in mortality and incidence for major sites of cancer by education level in a Japanese population. Ann. Epidemiol. 18, 584-591 (2008).
25. A. Stewart, A-bomb data: detection of bias in the Life Span Study cohort. Environ. Health Perspect. 105 (Suppl 6), 1519-1521 (1997).
26. D. A. Pierce, M. Vaeth and Y. Shimizu, Selection bias in cancer risk estimation from A-bomb survivors. Radiat. Res. 167, 735-741 (2007).
27. N. Nakamura, A hypothesis: Radiation-related leukemia is mainly attributable to the small number of people who carry pre-existing clonally expanded preleukemic cells. Radiat. Res. 163, 258-265 (2005).